Gatuzosiran (sodium)
Gatuzosiran sodium, a siRNA, is a 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) synthesis reducer. It is used for the study of fatty liver disease.
Product Specifications
UNSPSC
12352208
Target
17β-HSD
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[Gatuzosiran(sodium)]
Molecular Formula
C493H609F11N163Na44O311P43S7
Molecular Weight
16570.80
References & Citations
[1]WHO Drug Information - Vol. 38 , No. 4, 2024
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bs-5907R-BF555-01 20 µL
Ferritin Heavy Chain/FTH1 Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Ask
View Details 
bs-5907R-BF555-02 100 µL
Ferritin Heavy Chain/FTH1 Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Ask
View Details 
MBS6348918-01 0.1 mL
SMC3, ID (SMC3, BAM, BMH, CSPG6, SMC3L1, Structural maintenance of chromosomes protein 3, Basement membrane-associated chondroitin proteoglycan, Chondroitin sulfate proteoglycan 6, Chromosome-associated polypeptide) (MaxLight 405)
Ask
View Details